FDA Inspection
Elyse S. Rafal, M.D.Elyse S. Rafal, M.D. – FDA Inspection, Nov 24, 2025
Record Details
This FDA Inspection record concerns Elyse S. Rafal, M.D., with an inspection on November 24, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 699fa502-bb8f-452f-9c73-24927d307fa3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1292742
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Elyse S. Rafal, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 17, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Elyse S. Rafal, M.D.
- FDA Inspection 1247249 - 2024-08-01
- FDA Inspection 1192289 - 2022-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.